These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 31567014)

  • 21. Scavenging dicarbonyls with 5'-O-pentyl-pyridoxamine increases HDL net cholesterol efflux capacity and attenuates atherosclerosis and insulin resistance.
    Huang J; Tao H; Yancey PG; Leuthner Z; May-Zhang LS; Jung JY; Zhang Y; Ding L; Amarnath V; Liu D; Collins S; Davies SS; Linton MF
    Mol Metab; 2023 Jan; 67():101651. PubMed ID: 36481344
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hematopoietic stem/progenitor cell proliferation and differentiation is differentially regulated by high-density and low-density lipoproteins in mice.
    Feng Y; Schouteden S; Geenens R; Van Duppen V; Herijgers P; Holvoet P; Van Veldhoven PP; Verfaillie CM
    PLoS One; 2012; 7(11):e47286. PubMed ID: 23144813
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Suppressed monocyte recruitment drives macrophage removal from atherosclerotic plaques of Apoe-/- mice during disease regression.
    Potteaux S; Gautier EL; Hutchison SB; van Rooijen N; Rader DJ; Thomas MJ; Sorci-Thomas MG; Randolph GJ
    J Clin Invest; 2011 May; 121(5):2025-36. PubMed ID: 21505265
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Deficiency of ATP-binding cassette transporters A1 and G1 in macrophages increases inflammation and accelerates atherosclerosis in mice.
    Westerterp M; Murphy AJ; Wang M; Pagler TA; Vengrenyuk Y; Kappus MS; Gorman DJ; Nagareddy PR; Zhu X; Abramowicz S; Parks JS; Welch C; Fisher EA; Wang N; Yvan-Charvet L; Tall AR
    Circ Res; 2013 May; 112(11):1456-65. PubMed ID: 23572498
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HDL promotes rapid atherosclerosis regression in mice and alters inflammatory properties of plaque monocyte-derived cells.
    Feig JE; Rong JX; Shamir R; Sanson M; Vengrenyuk Y; Liu J; Rayner K; Moore K; Garabedian M; Fisher EA
    Proc Natl Acad Sci U S A; 2011 Apr; 108(17):7166-71. PubMed ID: 21482781
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pitavastatin: novel effects on lipid parameters.
    Chapman MJ
    Atheroscler Suppl; 2011 Nov; 12(3):277-84. PubMed ID: 22152282
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hematopoietic arginase 1 deficiency results in decreased leukocytosis and increased foam cell formation but does not affect atherosclerosis.
    Ren B; Van Kampen E; Van Berkel TJ; Cruickshank SM; Van Eck M
    Atherosclerosis; 2017 Jan; 256():35-46. PubMed ID: 27998825
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ApoE-dependent modulation of HDL and atherosclerosis by G2A in LDL receptor-deficient mice independent of bone marrow-derived cells.
    Parks BW; Srivastava R; Yu S; Kabarowski JH
    Arterioscler Thromb Vasc Biol; 2009 Apr; 29(4):539-47. PubMed ID: 19164809
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enhancing Atherosclerosis Regression in Diabetic Mice Through Apo AI (Apolipoprotein AI).
    Rader DJ
    Circulation; 2019 Oct; 140(14):1185-1187. PubMed ID: 31567013
    [No Abstract]   [Full Text] [Related]  

  • 30. Liver ABCA1 deletion in LDLrKO mice does not impair macrophage reverse cholesterol transport or exacerbate atherogenesis.
    Bi X; Zhu X; Duong M; Boudyguina EY; Wilson MD; Gebre AK; Parks JS
    Arterioscler Thromb Vasc Biol; 2013 Oct; 33(10):2288-96. PubMed ID: 23814116
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CER-001, a HDL-mimetic, stimulates the reverse lipid transport and atherosclerosis regression in high cholesterol diet-fed LDL-receptor deficient mice.
    Tardy C; Goffinet M; Boubekeur N; Ackermann R; Sy G; Bluteau A; Cholez G; Keyserling C; Lalwani N; Paolini JF; Dasseux JL; Barbaras R; Baron R
    Atherosclerosis; 2014 Jan; 232(1):110-8. PubMed ID: 24401224
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pegylation of high-density lipoprotein decreases plasma clearance and enhances antiatherogenic activity.
    Murphy AJ; Funt S; Gorman D; Tall AR; Wang N
    Circ Res; 2013 Jun; 113(1):e1-e9. PubMed ID: 23613182
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Short-Term Acyl-CoA:Cholesterol Acyltransferase Inhibition, Combined with Apoprotein A1 Overexpression, Promotes Atherosclerosis Inflammation Resolution in Mice.
    Amengual J; Ogando Y; Nikain C; Quezada A; Qian K; Vaisar T; Fisher EA
    Mol Pharmacol; 2021 Mar; 99(3):175-183. PubMed ID: 33384285
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of macrophage proliferation dominates plaque regression in response to cholesterol lowering.
    Härdtner C; Kornemann J; Krebs K; Ehlert CA; Jander A; Zou J; Starz C; Rauterberg S; Sharipova D; Dufner B; Hoppe N; Dederichs TS; Willecke F; Stachon P; Heidt T; Wolf D; von Zur Mühlen C; Madl J; Kohl P; Kaeser R; Boettler T; Pieterman EJ; Princen HMG; Ho-Tin-Noé B; Swirski FK; Robbins CS; Bode C; Zirlik A; Hilgendorf I
    Basic Res Cardiol; 2020 Dec; 115(6):78. PubMed ID: 33296022
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased cholesterol efflux in apolipoprotein AI (ApoAI)-producing macrophages as a mechanism for reduced atherosclerosis in ApoAI((-/-)) mice.
    Major AS; Dove DE; Ishiguro H; Su YR; Brown AM; Liu L; Carter KJ; Linton MF; Fazio S
    Arterioscler Thromb Vasc Biol; 2001 Nov; 21(11):1790-5. PubMed ID: 11701467
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Apolipoprotein A-I protection against atherosclerosis is dependent on genetic background.
    Sontag TJ; Krishack PA; Lukens JR; Bhanvadia CV; Getz GS; Reardon CA
    Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):262-9. PubMed ID: 24334873
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Loss of Transcription Factor CREBH Accelerates Diet-Induced Atherosclerosis in Ldlr-/- Mice.
    Park JG; Xu X; Cho S; Lee AH
    Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):1772-81. PubMed ID: 27417587
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MicroRNA 302a is a novel modulator of cholesterol homeostasis and atherosclerosis.
    Meiler S; Baumer Y; Toulmin E; Seng K; Boisvert WA
    Arterioscler Thromb Vasc Biol; 2015 Feb; 35(2):323-31. PubMed ID: 25524771
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Procollagen C-endopeptidase Enhancer Protein 2 (PCPE2) Reduces Atherosclerosis in Mice by Enhancing Scavenger Receptor Class B1 (SR-BI)-mediated High-density Lipoprotein (HDL)-Cholesteryl Ester Uptake.
    Pollard RD; Blesso CN; Zabalawi M; Fulp B; Gerelus M; Zhu X; Lyons EW; Nuradin N; Francone OL; Li XA; Sahoo D; Thomas MJ; Sorci-Thomas MG
    J Biol Chem; 2015 Jun; 290(25):15496-15511. PubMed ID: 25947382
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.